DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

Oppenheimer Initiates Coverage On Voyager Therapeutics with Outperform Rating, Announces $26 Price Target

Oppenheimer analyst Jay Olson initiates coverage on Voyager Therapeutics (NASDAQ:VYGR) with a Outperform rating and a $26 price target.

Benzinga · 02/06/2020 10:01

Oppenheimer analyst Jay Olson initiates coverage on Voyager Therapeutics (NASDAQ:VYGR) with a Outperform rating and a $26 price target.